Denali Therapeutics Inc

/Denali Therapeutics Inc

Their goal is to discover and develop therapeutics to defeat degeneration.

Symbol

Price Range
TBD

Anticipated Shares
13,880,000

Effective Date
December 8, 2017

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange